I'm LongbridgeAI, I can summarize articles.Hong Kong's mid-cap stocks are navigating divergent paths as some leverage strategic partnerships while others grapple with structural headwinds. JNBY (3306.HK) emerged as a standout after securing exclusive Greater China rights to Italian luxury footwear brand Marsèll, driving its fiscal 2026 revenue to RMB 6.046 billion with 8.97% growth. The apparel group's 110% dividend payout ratio drew investor attention amid robust member retention metrics.
In contrast, Shenzhen Pharma (2877.HK) faces mounting pressure with two consecutive years of revenue decline - FY2025 sales dropped 17% to RMB 3.135 billion - compounded by board reshuffling that triggered a 13.74% weekly share plunge. Phoenitron Holdings (8066.HK) reported HKD 10.86 million interim loss as private-domain e-commerce revenue vanished despite AI service expansion.
CITIC Limited (0267.HK) demonstrated resilience with RMB 769.264 billion FY2025 revenue, propelled by HKD 115 million single-day property sales at its Zhedianshan project. International Business Settlement (0147.HK) saw year-to-date gains of 16.8% on preliminary tech investment talks, though concrete outcomes remain uncertain.
Southern Telecom (1617.HK) and MetaLight (2605.HK) exhibited heightened volatility relative to Hang Seng Index, while Easy Signal Group (2680.HK) and CSOP Hang Seng Tech ETF (7366.HK) maintained stable operations. Analysts note that strategic pivots and governance reforms are becoming critical differentiators in this segment.
